CO5631437A2 - Parecoxib sodico cristalino - Google Patents

Parecoxib sodico cristalino

Info

Publication number
CO5631437A2
CO5631437A2 CO04090186A CO04090186A CO5631437A2 CO 5631437 A2 CO5631437 A2 CO 5631437A2 CO 04090186 A CO04090186 A CO 04090186A CO 04090186 A CO04090186 A CO 04090186A CO 5631437 A2 CO5631437 A2 CO 5631437A2
Authority
CO
Colombia
Prior art keywords
parecoxib
sodium
accordance
sodico
cristalino
Prior art date
Application number
CO04090186A
Other languages
English (en)
Spanish (es)
Inventor
Ahmad Sheikh
Thomas R Borchardt
Leonard J Ferro
Gerald D Danzer
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Publication of CO5631437A2 publication Critical patent/CO5631437A2/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06Lysergic acid amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CO04090186A 2002-03-15 2004-09-10 Parecoxib sodico cristalino CO5631437A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36456702P 2002-03-15 2002-03-15
US41798702P 2002-10-11 2002-10-11

Publications (1)

Publication Number Publication Date
CO5631437A2 true CO5631437A2 (es) 2006-04-28

Family

ID=28045416

Family Applications (1)

Application Number Title Priority Date Filing Date
CO04090186A CO5631437A2 (es) 2002-03-15 2004-09-10 Parecoxib sodico cristalino

Country Status (18)

Country Link
US (1) US20030232871A1 (https=)
EP (1) EP1485362A1 (https=)
JP (1) JP2005529084A (https=)
KR (1) KR100763045B1 (https=)
CN (1) CN1642926A (https=)
AR (1) AR038985A1 (https=)
AU (1) AU2003220180A1 (https=)
BR (1) BR0308431A (https=)
CA (1) CA2478500A1 (https=)
CO (1) CO5631437A2 (https=)
IL (1) IL163780A0 (https=)
MX (1) MXPA04008932A (https=)
MY (1) MY148518A (https=)
NZ (1) NZ535951A (https=)
PL (1) PL372880A1 (https=)
RU (1) RU2300529C2 (https=)
TW (1) TW200400949A (https=)
WO (1) WO2003078408A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050143431A1 (en) * 2003-04-04 2005-06-30 Hetero Drugs Limited Novel crystalline forms of parecoxib sodium
CA2540895C (en) * 2003-10-02 2016-08-02 Elan Pharmaceuticals, Inc. Combinations of ziconotide and opioids for reducing pain
CA2551523A1 (en) * 2003-12-24 2005-07-21 Pharmacia Corporation Metal salts of parecoxib as prodrugs of the cox-2 inhibitor valdecoxib for the treatment of inflammation, pain and/or fever
ITMI20040019A1 (it) * 2004-01-12 2004-04-12 Univ Bari Derivati isossazolici e loro impiego come inibitori della ciclossigenasi
US7796785B2 (en) * 2005-03-03 2010-09-14 Fujifilm Corporation Image extracting apparatus, image extracting method, and image extracting program
US20080108664A1 (en) 2005-12-23 2008-05-08 Liu Belle B Solid-state form of AMG 706 and pharmaceutical compositions thereof
US7989450B2 (en) 2008-01-11 2011-08-02 Universita' Degli Studi Di Bari Functionalized diarylisoxazoles inhibitors of ciclooxygenase
GB0919757D0 (en) * 2009-11-12 2009-12-30 Johnson Matthey Plc Polymorphs of bromfenac sodium and methods for preparing bromfenac sodium polymorphs
US8299295B2 (en) * 2009-10-15 2012-10-30 Johnson Matthey Public Limited Company Polymorphs of bromfenac sodium and methods for preparing bromfenac sodium polymorphs
CN105726496B (zh) * 2014-12-12 2019-05-28 湖南科伦药物研究有限公司 一种帕瑞昔布钠冻干粉剂、其制备方法及其粉剂产品
CN105125506A (zh) * 2015-08-18 2015-12-09 上海秀新臣邦医药科技有限公司 一种注射用帕瑞昔布钠及其制备方法
CN106580893A (zh) * 2016-12-26 2017-04-26 上药东英(江苏)药业有限公司 一种帕瑞昔布钠冻干粉针制剂
CN106692079A (zh) * 2016-12-26 2017-05-24 上药东英(江苏)药业有限公司 一种帕瑞昔布钠长效冻干粉针制剂
CN117003769B (zh) * 2023-07-11 2024-11-22 中国科学院宁波材料技术与工程研究所 氯诺昔康复合物、氯诺昔康-小檗碱共晶及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE233743T1 (de) 1996-04-12 2003-03-15 Searle & Co N-((4-(5-methyl-3-phenylisoxazol-4- yl)phenyl)sulphonylpropylamid und sein natriumsalz als pro-pharmakon von cox-2 inhibitoren
DE69729946T2 (de) * 1996-10-15 2005-01-20 G.D. Searle Llc Verwendung von cyclooxygenase-2 inhibitoren zur behandlung und verbeugung von neoplasia
PE20021017A1 (es) * 2001-04-03 2002-11-24 Pharmacia Corp Composicion parenteral reconstituible
IL161086A0 (en) * 2001-10-02 2004-08-31 Pharmacia Corp Method for preparing benzenesulfonyl compounds

Also Published As

Publication number Publication date
CA2478500A1 (en) 2003-09-25
RU2300529C2 (ru) 2007-06-10
TW200400949A (en) 2004-01-16
BR0308431A (pt) 2005-01-18
WO2003078408A1 (en) 2003-09-25
AR038985A1 (es) 2005-02-02
IL163780A0 (en) 2005-12-18
MY148518A (en) 2013-04-30
CN1642926A (zh) 2005-07-20
US20030232871A1 (en) 2003-12-18
KR20040095288A (ko) 2004-11-12
KR100763045B1 (ko) 2007-10-04
EP1485362A1 (en) 2004-12-15
JP2005529084A (ja) 2005-09-29
PL372880A1 (en) 2005-08-08
AU2003220180A1 (en) 2003-09-29
RU2004127585A (ru) 2005-04-10
NZ535951A (en) 2006-02-24
MXPA04008932A (es) 2004-11-26

Similar Documents

Publication Publication Date Title
CO5631437A2 (es) Parecoxib sodico cristalino
EP1126849A4 (en) HETEROCYCLIC POTASSIUM CHANNEL INHIBITORS
ATE423557T1 (de) Carbocyclische kaliumkanalhemmer
CY1106870T1 (el) Σταθεροποιηση ραπαμυκινης ή παραγωγων ραπαμυκινης
UA39099C2 (uk) Циклічні азотовмісні похідні, суміш їх ізомерів або окремі ізомери, або їх солі
DE60112055D1 (de) Inhibitoren von gamma-secretase
MY139235A (en) One step process for the preparation of anticonvulsant derivatives
SE0101108D0 (sv) A quaternary ammonium alkyl hydroxyethyl cellulose ether as a conditioner for hair and skin
NO20021379L (no) Benzodiazepin-derivater, fremstilling og anvendelse derav
BR9612318A (pt) "métodos de tratamento com compostos tendo atividade especìfica ou seletiva sobre o receptor de raralfa"
HRP20020429B8 (hr) Polimorfni oblik atorvastatin kalcija
SI1410791T1 (sl) Peroralna galenska oblika, ki obsega metformin insredstvo za pospeĺ evanje absorpcije
MX2024012348A (es) Forma cristalina de lanifibranor
DK0665844T3 (da) Substituerede benzylaminoquinuclidinforbindelser som antagonister af substans P
CO4970820A1 (es) Sal de bisulfato del inhibidor de la vih-proteasa
DE60012188D1 (de) Fungizide
DE60329533D1 (de) Cyclische sulfamide zur inhibierung von gamma-sekretase
DE69804845D1 (de) Talkum enthaltende polypropylenzusammensetzungen
DE69928655D1 (de) Substituierte porphyrine
BR9909602B1 (pt) caixa para artigos de fumo.
DE69936285D1 (de) INDOLOi2,1-BöQUINAZOLIN-6,12-DIONE ANTIMALARIA DERIVATE UND METHODEN ZUR BEHANDLUNG VON MALARIA
DE59103664D1 (de) Verfahren zur Inhibierung und Zerstörung von Peroxiden in Dialkylethern.
PT1009436E (pt) Derivado de acridina para aumentar a biodisponibilidade oral do taxol
DE69130326D1 (de) Piperidin-verbindungen, ihre darstellung und ihre verwendung
BR9914731A (pt) Processo para a obtenção de gama-decalactona

Legal Events

Date Code Title Description
FC Application refused